Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kattan, M. W.
Right arrow Articles by Brennan, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kattan, M. W.
Right arrow Articles by Brennan, M. F.
Journal of Clinical Oncology, Vol 21, Issue 19 (October), 2003: 3647-3650
© 2003 American Society for Clinical Oncology

Postoperative Nomogram for Disease-Specific Survival After an R0 Resection for Gastric Carcinoma

Michael W. Kattan, Martin S. Karpeh, Madhu Mazumdar, Murray F. Brennan

From the Departments of Urology, Epidemiology and Biostatistics, and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.

Address reprint requests to Murray F. Brennan, MD, Memorial Sloan-Kettering Cancer Center, Department of Surgery, 1275 York Ave, C1275 New York, NY 10021; e-mail: brennanm{at}mskcc.org.

Purpose: Few published studies have addressed individual patient risk after R0 resection for gastric cancer. We developed and internally validated a nomogram that combines these factors to predict the probability of 5-year gastric cancer–specific survival on the basis of 1,039 patients treated at a single institution.

Methods: Nomogram predictor variables included age, sex, primary site (distal one-third, middle one-third, gastroesophageal junction, and proximal one-third), Lauren histotype (diffuse, intestinal, mixed), number of positive lymph nodes resected, number of negative lymph nodes resected, and depth of invasion. Death as a result of gastric cancer was the predicted end point. The concordance index was used as an accuracy measure, with bootstrapping to correct for optimistic bias. Calibration plots were constructed.

Results: Gastric cancer–specific survival at 5 years was 50%. A nomogram was constructed on the basis of a Cox regression model. The bootstrap-corrected concordance index was 0.80. When compared with the predictive ability of American Joint Committee on Cancer stage, the nomogram discrimination was superior (P < .001). Nomogram calibration appeared to be excellent.

Conclusion: A nomogram was developed to predict 5-year disease-specific survival after R0 resection for gastric cancer. This tool should be useful for patient counseling, follow-up scheduling, and clinical trial eligibility determination.

Supported by a grant from the Gelb Foundation.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. F. Shariat, P. I. Karakiewicz, N. Suardi, and M. W. Kattan
Comparison of Nomograms With Other Methods for Predicting Outcomes in Prostate Cancer: A Critical Analysis of the Literature
Clin. Cancer Res., July 15, 2008; 14(14): 4400 - 4407.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. R. Weiser, R. G. Landmann, M. W. Kattan, M. Gonen, J. Shia, J. Chou, P. B. Paty, J. G. Guillem, L. K. Temple, D. Schrag, et al.
Individualized Prediction of Colon Cancer Recurrence Using a Nomogram
J. Clin. Oncol., January 20, 2008; 26(3): 380 - 385.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. S. Gold, L. H. Tang, M. Gonen, D. G. Coit, M. F. Brennan, and P. J. Allen
Utility of a Prognostic Nomogram Designed for Gastric Cancer in Predicting Outcome of Patients with R0 Resected Duodenal Adenocarcinoma.
Ann. Surg. Oncol., November 1, 2007; 14(11): 3159 - 3167.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
E. Briasoulis, M. Fatouros, and D. H. Roukos
Level I Evidence in Support of Perioperative Chemotherapy for Operable Gastric Cancer: Sufficient for Wide Clinical Use?
Ann. Surg. Oncol., October 1, 2007; 14(10): 2691 - 2695.
[Full Text] [PDF]


Home page
BloodHome page
W. G. Wierda, S. O'Brien, X. Wang, S. Faderl, A. Ferrajoli, K.-A. Do, J. Cortes, D. Thomas, G. Garcia-Manero, C. Koller, et al.
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
Blood, June 1, 2007; 109(11): 4679 - 4685.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C.-Y. Wu, M.-S. Wu, E.-P. Chiang, Y.-J. Chen, C.-J. Chen, N.-H. Chi, Y.-T. Shih, G.-H. Chen, and J.-T. Lin
Plasma Matrix Metalloproteinase-9 Level Is Better than Serum Matrix Metalloproteinase-9 Level to Predict Gastric Cancer Evolution
Clin. Cancer Res., April 1, 2007; 13(7): 2054 - 2060.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
A. P. Barbour, N. P. Rizk, M. Gonen, L. Tang, M. S. Bains, V. W. Rusch, D. G. Coit, and M. F. Brennan
Lymphadenectomy for Adenocarcinoma of the Gastroesophageal Junction (GEJ): Impact of Adequate Staging on Outcome
Ann. Surg. Oncol., February 1, 2007; 14(2): 306 - 316.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. E. Schwarz and D. D. Smith
Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage
Ann. Surg. Oncol., February 1, 2007; 14(2): 317 - 328.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Marrelli and F. Roviello
Prognostic Score in Gastric Cancer Patients
Ann. Surg. Oncol., February 1, 2007; 14(2): 362 - 364.
[Full Text] [PDF]


Home page
The OncologistHome page
D. W. Gee and D. W. Rattner
Management of Gastroesophageal Tumors
Oncologist, February 1, 2007; 12(2): 175 - 185.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. F. Shariat, P. I. Karakiewicz, G. S. Palapattu, G. E. Amiel, Y. Lotan, C. G. Rogers, A. Vazina, P. J. Bastian, A. Gupta, A. I. Sagalowsky, et al.
Nomograms Provide Improved Accuracy for Predicting Survival after Radical Cystectomy.
Clin. Cancer Res., November 15, 2006; 12(22): 6663 - 6676.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. M. Lagarde, F. J.W. ten Kate, J. B. Reitsma, O. R.C. Busch, and J. J. B. van Lanschot
Prognostic Factors in Adenocarcinoma of the Esophagus or Gastroesophageal Junction
J. Clin. Oncol., September 10, 2006; 24(26): 4347 - 4355.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
International Bladder Cancer Nomogram Consortium
Postoperative Nomogram Predicting Risk of Recurrence After Radical Cystectomy for Bladder Cancer
J. Clin. Oncol., August 20, 2006; 24(24): 3967 - 3972.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. L. V. Costa, K. de Cassia Braga Ribeiro, M. A. C. Machado, A. C. L. V. Costa, and A. L. Montagnini
Prognostic Score in Gastric Cancer: The Importance of a Conjoint Analysis of Clinical, Pathologic, and Therapeutic Factors
Ann. Surg. Oncol., June 1, 2006; 13(6): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. R. Ferrone, M. W. Kattan, J. S. Tomlinson, S. P. Thayer, M. F. Brennan, and A. L. Warshaw
Validation of a Postresection Pancreatic Adenocarcinoma Nomogram for Disease-Specific Survival
J. Clin. Oncol., October 20, 2005; 23(30): 7529 - 7535.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. D. Smith, R. R. Schwarz, and R. E. Schwarz
Impact of Total Lymph Node Count on Staging and Survival After Gastrectomy for Gastric Cancer: Data From a Large US-Population Database
J. Clin. Oncol., October 1, 2005; 23(28): 7114 - 7124.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. P.M. Jansen, H. Boot, M. Verheij, and C. J.H. van de Velde
Optimal Locoregional Treatment in Gastric Cancer
J. Clin. Oncol., July 10, 2005; 23(20): 4509 - 4517.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Bentrem, A. Wilton, M. Mazumdar, M. Brennan, and D. Coit
The Value of Peritoneal Cytology as a Preoperative Predictor in Patients With Gastric Carcinoma Undergoing a Curative Resection
Ann. Surg. Oncol., May 1, 2005; 12(5): 347 - 353.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. A. Ajani
Operate on My Stomach Cancer? Oh, No--Not You, or Not Yet!
J. Clin. Oncol., May 1, 2004; 22(9): 1763 - 1764.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online